Soligenix
SNGX
#10411
Rank
C$16.03 M
Marketcap
C$1.59
Share price
-0.87%
Change (1 day)
-39.33%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.53 Million

According to Soligenix's latest financial reports the company's total debt is C$0.53 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$2.13 M-54.03%
2023-12-31C$4.63 M-66.64%
2022-12-31C$13.89 M9.44%
2021-12-31C$12.69 M-5.22%
2020-12-31C$13.39 M7962.06%
2019-12-31C$0.16 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31C$0.4 M-90.77%
2014-12-31C$4.39 M-50.11%
2013-12-31C$8.81 M
2004-12-31C$0.13 M-70.1%
2003-12-31C$0.46 M-59.6%
2002-12-31C$1.15 M233.74%
2001-12-31C$0.34 M-28.6%
2000-12-31C$0.48 M-14.47%
1999-12-31C$0.56 M-8.01%
1998-12-31C$0.61 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$66.84 B 12,448,283.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$89.20 B 16,610,816.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$33.30 B 6,201,913.22%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$25.9 M 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.83 B 4,439,277.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.92 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA